Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Lidocaine and Esketamine TAP Block for Postoperative Pain
NCT05122338Unknown
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Dec 2021
- Primary completion
- May 2022
- Modality
- Small Molecules, Drug Delivery Systems
01
Overview
Randomised, double-blind trial of lidocaine + prilocaine and esketamine in postoperative pain (4 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoint: Postoperative opioid consumption. Status: unknown.
02
Drugs
lidocaine + prilocaineesketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05122338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05122338.